ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,304, issued on March 25, was assigned to Albert Einstein College of Medicine (Bronx, N.Y.) and Victoria Link Ltd. (Wellington, New Zealand).

"Compounds and methods for treatment of bacterial infections" was invented by Steven C. Almo (Pelham, N.Y.), Tyler Grove (Bronx, N.Y.), Lawrence D. Harris (Lower Hutt, New Zealand) and Gary B. Evans (Lower Hutt, New Zealand).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document discloses a novel class of compounds for inhibiting bacterial growth and treating bacterial infection. The compounds target a key step of the futalosine pathway and therefore are effective for the selective inhibition of certain b...